ETOMIDATE INJECTION USP

marcan pharmaceuticals inc🇨🇦 Health Canada

Approval Id: caa5361e90a79045
Drug Approval Canada Name: ETOMIDATE INJECTION USP
Product Name: ETOMIDATE INJECTION USP
Status: Marketed
Status Date: 2022-05-20
Original Market Date: 2022-05-20
Din: 02525453
Drug Class: Human
Dosage Form: Solution
Route Of Administration: Intravenous
Schedule: Prescription
Ahfs: 28:04.08
Atc Original: N01AX07 ETOMIDATE
Atc Name: n 01 ax 07
Aig Number: 0162234001
Company Name: marcan pharmaceuticals inc
Company Address: 2 Gurdwara Rd., Suite 112, Ottawa, Ontario, Canada, K2E 1A2

ETOMIDATE

2 MG / ML

Authorized

Agency

Health Canada

Country

🇨🇦

Approval Date

Jul 4, 2025

Approval ID

caa5361e90a79045

Type

Standard